← All companies

RNXT

RenovoRx, Inc.

RNXT Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.06

+0.12 +12.65%

Key statistics

from XBRL data in SEC filings

Market cap

$47.8M

Revenue (TTM)

$1.49M

Net income (TTM)

-$12.3M

EPS (TTM)

$-0.33

P/E ratio

—

Dividend yield

—

Free cash flow

-$11.0M

Cash

$12.4M

Total assets

$14.0M

Gross margin

78.7%

52-week range

$0.70 – $1.45

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Delisting notice or listing-rule failure Jul 2, 2026 8-K Shareholder vote results Jun 30, 2026 10-K/A Fiscal year ended 2025-12-31 May 15, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Results of operations (earnings release); Other events Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Director or officer change Mar 27, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 23, 2026 8-K Director or officer change; Other events Feb 6, 2026 8-K Delisting notice or listing-rule failure Jan 2, 2026 8-K Entered a material agreement Nov 14, 2025 8-K Results of operations (earnings release); Other events Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release); Other events Aug 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Shareholder vote results Jun 25, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Other events May 15, 2025 8-K Results of operations (earnings release); Other events Apr 1, 2025 10-K Fiscal year ended 2024-12-31 Apr 1, 2025 8-K Entered a material agreement; Other events Feb 10, 2025 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Other events Sep 25, 2024 8-K Changed accountants Aug 16, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change; Shareholder vote results Jun 7, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Changed accountants; Director or officer change May 3, 2024 8-K Other events Apr 18, 2024 8-K Other events Apr 16, 2024 8-K Unregistered sale of equity; Regulation FD disclosure; Other events Apr 15, 2024 8-K Entered a material agreement; Other events Apr 9, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Director or officer change Mar 14, 2024 8-K Delisting notice or listing-rule failure; Director or officer change Feb 23, 2024 8-K Director or officer change Feb 9, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Jan 29, 2024 8-K Other events Jan 2, 2024